dacarbazine has been researched along with interleukin-8 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aulitzky, WE; Bemb, W; Huber, C; Kolbe, K; Peschel, C; Schönbohn, H; Schuler, M | 1 |
| Bar-Eli, M; Lev, DC; McGary, EC; Mills, L; Price, JE; Ruiz, M | 1 |
| Graziani, G; Tentori, L | 1 |
| Ananthaswamy, HN; Bar-Eli, M; Lev, DC; McGary, EC; Melinkova, VO; Miller, C; Onn, A; Price, JE; Ruiz, M; Stone, V | 1 |
| Brennecke, S; Deichmann, M; Kurzen, H; Naeher, H | 1 |
| Biasco, G; Casamassima, A; Chiarion-Sileni, V; Freschi, A; Galligioni, E; Guida, M; Nanni, O; Nortilli, R; Palma, MD; Picozzo, J; Ravaioli, A; Riccobon, A; Ridolfi, R; Romanini, A | 1 |
| Bar-Eli, M; Lev, DC; Melnikova, VO; Villares, GJ; Zigler, M | 1 |
| Ahn, NG; Dallaglio, K; Ellis, LZ; Fujita, M; Gonzalez, R; Lewis, KD; Liu, W; Luo, Y; McCarter, MD; Norris, DA; Robinson, SE; Robinson, WA; Roop, DR; Spritz, RA; Takeda, M | 1 |
| Czyz, ME; Hartman, ML; Koprowska, K; Sztiller-Sikorska, M | 1 |
1 review(s) available for dacarbazine and interleukin-8
| Article | Year |
|---|---|
Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; CD146 Antigen; Dacarbazine; Disease Progression; Drug Resistance, Neoplasm; Humans; Immunotherapy; Interleukin-8; Melanoma; Neoplasm Metastasis; Skin Neoplasms | 2008 |
2 trial(s) available for dacarbazine and interleukin-8
| Article | Year |
|---|---|
Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma.
Topics: Adult; Aged; Angiogenic Proteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Fibroblast Growth Factor 2; Humans; Interferon-alpha; Interleukin-2; Interleukin-8; Male; Melanoma; Middle Aged; Neoplasm Staging; Platelet-Derived Growth Factor; Prospective Studies; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vindesine | 2005 |
Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytokines; Dacarbazine; Female; Humans; Immunologic Factors; Interleukin-10; Interleukin-12; Interleukin-2; Interleukin-6; Interleukin-8; Male; Melanoma; Middle Aged; Receptors, Interleukin-6; Skin Neoplasms; Survival Analysis; Survival Rate; Vinblastine | 2006 |
6 other study(ies) available for dacarbazine and interleukin-8
| Article | Year |
|---|---|
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.
Topics: Adolescent; Adult; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Dacarbazine; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-2; Interleukin-6; Interleukin-8; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neutropenia; Nimustine; Prospective Studies; Sialoglycoproteins; Tumor Necrosis Factor-alpha; Vincristine | 1995 |
Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy.
Topics: Cell Line, Tumor; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Interleukin-8; Melanoma; Mitogen-Activated Protein Kinases; NF-kappa B; Transcription Factor AP-1; Transcription, Genetic; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A | 2003 |
Correspondence re: DC Lev et al., Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy. Mol Cancer Ther, 2003;2(8):753-63.
Topics: Cell Line, Tumor; Dacarbazine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Interleukin-8; Melanoma; Mitogen-Activated Protein Kinases; NF-kappa B; Transcription Factor AP-1; Transcription, Genetic; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Melanoma; Mice; Mice, Nude; Skin Neoplasms; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Coloring Agents; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Interleukin-8; Melanoma; Mice; Mice, Nude; Paclitaxel; Side-Population Cells; Skin Neoplasms; Temozolomide; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
Parthenolide enhances dacarbazine activity against melanoma cells.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Interleukin-8; Melanoma; NF-kappa B; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Skin Neoplasms; Vascular Endothelial Growth Factor A | 2013 |